Effect of Elevated Intraocular Pressure in Glaucoma Patients During Femtolaser Cataract Surgery (FEMTOHTO)
The use of the femtosecond laser causes an increase in the intraocular pressure (IOP) between 100 mm Hg and 200 mm Hg for a period of about 80 seconds (suction phase).
If it is known that elevated IOP accelerates the degradation of retinal ganglion cells, whose axons form the optic nerve.
No data has been published to date on potential adverse effects of femtolaser cataract surgery performed in patients with glaucomatous optic neuropathy.
Since some time, spectral-domain optical coherence tomography (SD -OCT) provides a detailed analysis of ganglion cell complex (GCC) for which the loss is a marker of glaucomatous optic neuropathy. The resolution of this device, about a few microns, can detect even a tiny loss of this layer.
The investigators propose to evaluate the effects of elevated intraocular pressure in glaucoma patients undergoing femtolaser cataract surgery, studying the GCC through SD-OCT.
Studieoversigt
Status
Intervention / Behandling
Undersøgelsestype
Tilmelding (Faktiske)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiesteder
-
-
-
Paris, Frankrig, 75019
- Fondation ophtalmique Adolphe de Rothschild
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
- Barn
- Voksen
- Ældre voksen
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- scheduled bilateral cataract surgery
- bilateral known glaucoma confirmed at the preoperative consultation (glaucoma group) or absence of glaucoma in both eyes at confirmed the preoperative consultation (control group).
Exclusion Criteria:
- ophthalmologic pathology known other than glaucoma
diabetes
- untreated hypertension
- multiple sclerosis
- Graves' disease
- sarcoidosis
- patient taking toxic drug for the optic nerve and the retina
- neurodegenerative disease
- all general diseases that can affect the ocular structures
- eye surgery history
- patient's opposition to participation in the study, according to the law on research into routine care
- absence of affiliation to social security or to universal medical coverage
- legally protected patient
- pregnancy or breastfeeding
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Diagnostisk
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: Patient with glaucoma
Patient eligible for bilateral cataract surgery, with glaucoma.
Each patient is his own control.
The patient is treated with femtolaser surgery for one eye and with phacoemulsification for the other eye.
|
|
|
Andet: Patient without glaucoma
Patient eligible for bilateral cataract surgery, without glaucoma.
Each patient is his own control.
The patient is treated with femtolaser surgery for one eye and with the phacoemulsification for the other eye.
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Tidsramme |
|---|---|
|
In patient with glaucoma, measure of the thickness of the ganglion cell complex in the operated eye with femtosecond laser versus the operated eye with phacoemulsification.
Tidsramme: within the first 3 months after surgery
|
within the first 3 months after surgery
|
Samarbejdspartnere og efterforskere
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Primær færdiggørelse (Faktiske)
Studieafslutning (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Skøn)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- AGC_2014-19
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Femtolaser surgery
-
Clinique Victor PauchetRekruttering
-
Diakonessenhuis, UtrechtRekrutteringLivskvalitet | Søvnapnø, obstruktivHolland
-
Instituto de Investigación Sanitaria de la Fundación...RekrutteringPtosis, øjenlågSpanien
-
Royal Surrey County Hospital NHS Foundation TrustUkendtLivmoderhalskræft | Æggelederkræft | Peritoneal kræft | Neoplasma i æggestokkene | Ovarie neoplasma epitelialDet Forenede Kongerige
-
University of Colorado, DenverRekrutteringForbedret restitution efter operation | Gynækologisk sygdomForenede Stater
-
University Hospital, GrenobleAfsluttet
-
The Second Hospital of Shandong UniversityRekrutteringLungekræft | Kirurgi | ERASKina
-
Grupo Español de Rehabilitación MultimodalInstituto de Salud Carlos III; Instituto de Investigación Sanitaria AragónRekrutteringStørre operationSpanien
-
ARCAGY/ GINECO GROUPAfsluttetOvariekræft Stadium IIIC | Ovariekræft Stadium IV | Ovariekræft Stadium IIIbFrankrig
-
National Taiwan University HospitalIntuitive SurgicalRekrutteringKolelithiasis | CholedocholithiasisTaiwan